{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T11:52:34Z","timestamp":1792929154032,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,10,6]],"date-time":"2017-10-06T00:00:00Z","timestamp":1507248000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1053\/j.ajkd.2017.08.020","type":"journal-article","created":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T16:45:14Z","timestamp":1510677914000},"page":"225-235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Development of the Autosomal Dominant Polycystic Kidney Disease Impact Scale: A New Health-Related Quality-of-Life Instrument"],"prefix":"10.1053","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1034-9049","authenticated-orcid":false,"given":"Dorothee","family":"Oberdhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason C.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly B.","family":"Krasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank S.","family":"Czerwiec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron D.","family":"Hays","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlene B.","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald D.","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9569","key":"10.1053\/j.ajkd.2017.08.020_bib1","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","article-title":"Autosomal dominant polycystic kidney disease","volume":"369","author":"Torres","year":"2007","journal-title":"Lancet"},{"issue":"14","key":"10.1053\/j.ajkd.2017.08.020_bib2","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMcp0804458","article-title":"Autosomal dominant polycystic kidney disease","volume":"359","author":"Grantham","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1053\/j.ajkd.2017.08.020_bib3","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nrneph.2011.109","article-title":"Why kidneys fail in autosomal dominant polycystic kidney disease","volume":"7","author":"Grantham","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"10.1053\/j.ajkd.2017.08.020_bib4","series-title":"Polycystic Kidney Disease","first-page":"333","article-title":"Gabow PA 1996 PKD Chapter 13 Natural History ADPKD.pdf","author":"Gabow","year":"1996"},{"issue":"2","key":"10.1053\/j.ajkd.2017.08.020_bib5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/ki.2009.128","article-title":"Autosomal dominant polycystic kidney disease: the last 3 years","volume":"76","author":"Torres","year":"2009","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2017.08.020_bib6","first-page":"69","article-title":"Polycystic kidney disease: inheritance, pathophysiology, prognosis, and treatment","volume":"3","author":"Halvorson","year":"2010","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"8","key":"10.1053\/j.ajkd.2017.08.020_bib7","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.2215\/CJN.00780110","article-title":"Renal function and healthcare costs in patients with polycystic kidney disease","volume":"5","author":"Lentine","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2017.08.020_bib8","unstructured":"National Kidney and Urologic Diseases Information Clearinghouse. Polycystic Kidney Disease. Bethesda, MD; 2007. https:\/\/www.niddk.nih.gov\/-\/media\/FD324862F39546E88D22860766E3A9EA.ashx. Accessed September 23,\u00a02016."},{"issue":"5","key":"10.1053\/j.ajkd.2017.08.020_bib9","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/ndt\/gfv010","article-title":"A\u00a0painful inheritance\u2013patient perspectives on living with polycystic kidney disease: thematic synthesis of qualitative research","volume":"30","author":"Tong","year":"2015","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1053\/j.ajkd.2017.08.020_bib10","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1590\/S0101-28002011000200002","article-title":"Ansiedade, depress\u00e3o e qualidade de vida em pacientes com glomerulonefrite familiar ou doen\u00e7a renal polic\u00edstica autoss\u00f4mica dominante","volume":"33","author":"de Barros","year":"2011","journal-title":"J\u00a0Bras Nefrol"},{"issue":"3","key":"10.1053\/j.ajkd.2017.08.020_bib11","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.pmn.2009.03.002","article-title":"\u201cAn evil heritage\u201d: interview study of pain and autosomal dominant polycystic kidney disease","volume":"10","author":"Heiwe","year":"2009","journal-title":"Pain Manag Nurs"},{"issue":"2","key":"10.1053\/j.ajkd.2017.08.020_bib12","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1053\/j.ajkd.2013.08.017","article-title":"Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD stages 1-4: a cross-sectional study","volume":"63","author":"Miskulin","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1053\/j.ajkd.2017.08.020_bib13","doi-asserted-by":"crossref","first-page":"560","DOI":"10.2215\/CJN.02410508","article-title":"Quality of life in autosomal dominant polycystic kidney disease patients not yet on dialysis","volume":"4","author":"Rizk","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2017.08.020_bib14","series-title":"User\u2019s Manual for the SF-12v2 Health Survey","year":"2012"},{"issue":"5","key":"10.1053\/j.ajkd.2017.08.020_bib15","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF00451725","article-title":"Development of the Kidney Disease Quality of Life (KDQOLTM) instrument","volume":"3","author":"Hays","year":"1994","journal-title":"Qual Life Res"},{"issue":"2","key":"10.1053\/j.ajkd.2017.08.020_bib16","first-page":"129","article-title":"Pain assessment: global use of the Brief Pain Inventory","volume":"23","author":"Cleeland","year":"1994","journal-title":"Ann Acad Med Singapore"},{"issue":"6","key":"10.1053\/j.ajkd.2017.08.020_bib17","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1053\/j.ajkd.2003.08.025","article-title":"Pain in hemodialysis patients: prevalence, cause, severity, and management","volume":"42","author":"Davison","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2017.08.020_bib18","doi-asserted-by":"crossref","DOI":"10.4414\/smw.2013.13750","article-title":"Frequency and severity of pain and symptom distress among patients with chronic kidney disease receiving dialysis","author":"Gamondi","year":"2013","journal-title":"Swiss Med Wkly"},{"issue":"7","key":"10.1053\/j.ajkd.2017.08.020_bib19","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.nephro.2016.12.005","article-title":"[Quality of life in patients with autosomal dominant polycystic kidney disease] in French","volume":"13","author":"Lecardeur","year":"2017","journal-title":"N\u00e9phrol Th\u00e9r"},{"key":"10.1053\/j.ajkd.2017.08.020_bib20","unstructured":"Food and Drug Administration. Guidance for Industry Use in Medical Product Development to Support Labeling Claims Guidance for Industry. 2009."},{"issue":"8","key":"10.1053\/j.ajkd.2017.08.020_bib21","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jval.2011.06.013","article-title":"Content validity\u2014establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force Report: part 2\u2014assessing respondent understanding","volume":"14","author":"Patrick","year":"2011","journal-title":"Value Health"},{"issue":"8","key":"10.1053\/j.ajkd.2017.08.020_bib22","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jval.2011.06.014","article-title":"Content validity\u2014establishing and reporting the evidence in newly developed patient-reported outcomes (pro) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force Report: part 1\u2014eliciting concepts for\u00a0a new PRO instrument","volume":"14","author":"Patrick","year":"2011","journal-title":"Value Health"},{"issue":"4","key":"10.1053\/j.ajkd.2017.08.020_bib23","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1037\/h0040957","article-title":"Construct validity in psychological tests","volume":"52","author":"Cronbach","year":"1955","journal-title":"Psychol Bull"},{"key":"10.1053\/j.ajkd.2017.08.020_bib24","series-title":"Design and Analysis: A Researcher\u2019s Handbook","author":"Keppel","year":"1991"},{"key":"10.1053\/j.ajkd.2017.08.020_bib25","doi-asserted-by":"crossref","DOI":"10.1046\/j.1526-4610.2000.00030.x","article-title":"Validity and reliability of the Migraine-Specific Quality of Life Questionnaire (MSQ version 2.1)","author":"Martin","year":"2000","journal-title":"J\u00a0Head Face Pain"},{"issue":"297","key":"10.1053\/j.ajkd.2017.08.020_bib26","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF02310555","article-title":"Coefficient alpha and the internal structure of tests","volume":"16","author":"Cronbach","year":"1951","journal-title":"Psychometrika"},{"key":"10.1053\/j.ajkd.2017.08.020_bib27","series-title":"Psychometric Theory","author":"Nunnally","year":"1994"},{"key":"10.1053\/j.ajkd.2017.08.020_bib28","series-title":"Psychological Testing","author":"Anastasi","year":"1997"},{"issue":"5","key":"10.1053\/j.ajkd.2017.08.020_bib29","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1037\/0021-9010.89.5.792","article-title":"Alpha\u2019s standard error (ASE): an accurate and precise confidence interval estimate","volume":"89","author":"Duhachek","year":"2004","journal-title":"J\u00a0Appl Psychol"},{"issue":"3","key":"10.1053\/j.ajkd.2017.08.020_bib30","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1037\/1040-3590.7.3.309","article-title":"Constructing validity: basic issues in objective scale development","volume":"7","author":"Clark","year":"1995","journal-title":"Psychol Assess"},{"key":"10.1053\/j.ajkd.2017.08.020_bib31","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"key":"10.1053\/j.ajkd.2017.08.020_bib32","series-title":"Quality of Life","year":"2015"},{"issue":"1","key":"10.1053\/j.ajkd.2017.08.020_bib33","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0895-4356(94)90036-1","article-title":"Determining a minimal important change in a disease-specific Quality of Life Questionnaire","volume":"47","author":"Juniper","year":"1994","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1053\/j.ajkd.2017.08.020_bib34","author":"Nunnally","year":"1967","journal-title":"Psychometric Theory"},{"issue":"7","key":"10.1053\/j.ajkd.2017.08.020_bib35","doi-asserted-by":"crossref","first-page":"A512","DOI":"10.1016\/j.jval.2015.09.1479","article-title":"Health-related quality of life (HRQOL) measures in autosomal dominant polycystic kidney disease (ADPKD)","volume":"18","author":"Oberdhan","year":"2015","journal-title":"Value Health"},{"key":"10.1053\/j.ajkd.2017.08.020_bib36","unstructured":"Cheng R, Oberdhan D, Krasa H, Cole JC. Patient-reported pain in autosomal dominant polycystic kidney disease (ADPKD): Concept Stability Between Europe and United States (US) Focus Groups."},{"key":"10.1053\/j.ajkd.2017.08.020_bib37","unstructured":"Oberdhan D, Palsgrove A, Cole J, Blais J, Cheng R. Patient experience with pain related to autosomal dominant polycystic kidney disease (ADPKD). Presented at World Congress of Nephrology, March 15, 2015. https:\/\/doi.org\/10.13140\/RG.2.1.2771.4321."}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638617309514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638617309514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:03:33Z","timestamp":1759460613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638617309514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0272638617309514"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2017.08.020","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of the Autosomal Dominant Polycystic Kidney Disease Impact Scale: A New Health-Related Quality-of-Life Instrument","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2017.08.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}